1.       American Academy of Pediatrics, Clinical Practice Guideline, Subcommittee on Hyperbilirubinemia. Management of the newborn 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316.

2.       American Academy of Pediatrics, Joint Committee on Infant Hearing. Year 2007 position statement: Principles and guidelines for early hearing detection and intervention programs. Pediatrics 2007; 120: 898-921.

3.       Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour- specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999; 103: 6–14.

4.       Çoban A, İnce Z (eds). Neonatoloji: Tedavi, Girişimler, Sık Karşılaşılan Sorunlar, Hastalıklar ve İlaçlar. Yenidoğanda Hiperbilirubinemi bölümü. Lange çeviri. 1. baskı (2012): s. 498–510. İstanbul: İstanbul Tıp Kitabevi.

5.       Hansen TWH, Bratlid D. Physiology of neonatal unconjugated hyperbilirubinemia. In: Stevenson DK, Maisels MJ, Watchko JF, eds. Care of Jaundiced Neonate. New York: McGraw-Hill, 2012: 65-95.

6.       Keenan WJ, Novak KK, Sutherland JM, et al. Morbidity and mortality associated with exchange transfusion. Pediatrics 1985; 75:417

7.       Kemper AR, Newman TB, Slaughter JL, Maisels MJ, Watchko JF, Downs SM, Grout RW, Bundy DG, Stark AR, Bogen DL, Holmes AV, Feldman-Winter LB, Bhutani VK, Brown SR, Maradiaga Panayotti GM, Okechukwu K, Rappo PD, Russell TL. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022;1;150.

8.       Konana OS, Bahr TM, Strike HR, et al. Decision Accuracy and Safety of Transcutaneous Bilirubin Screening at Intermountain Healthcare. J Pediatr 2021; 228:53.

9.       Maisels MJ, Bhutani VK, Bogen D Newman TB, Stark AR, Watchko JF. Hyperbilirubinemia in the newborn infant ≥35 weeks gestation: an update with clarification. Pediatrics 2009; 124: 1193-1198.

10.   Maisels MJ, Newman TB. Prevention, screening and postnatal management of neonatal hyperbilirubinemia. In: Stevenson DK, Maisels MJ, Watchko JF, eds. Care of Jaundiced Neonate. New York: McGraw-Hill, 2012: 175-194.

11.   National Institute of Child Health and Clinical Excellence: Jaundice in newborn babies under 28 days.  https://www.nice. org.uk/guidance/cg98.

12.   Neyzi O, Ertuğrul T (eds). Pediatri. Yenidoğanda Sarılık Bölümü. 6. baskı.  İstanbul: Nobel Tıp Kitabevleri; 2020. s. 345-362.

13.   Odell GB, Poland RL, Nostrea E Jr. Neonatal hyperbilirubinemia. In: KlausnMH, Fanaroff A, eds. Care of the High –Risk Neonate. Philadelphia: WB Saunder, 1973, Chapter 11.

14.   Schwarz HP, Haberman BE, Ruddy RM. Hyperbilirubinemia. Current guidelines and emerging therapies. Pediatr Emer Care 2011; 27: 884-889.

15.   Shapiro SM. Definition of the clinical spectrum of kernicterus and bilirubin induced neurologic dysfunction (BIND). J Perinatol 2005; 25: 54-59.

16.   Türk Neonatoloji Derneği. Yenidoğan Sarılıklarında Yaklaşım, İzlem ve Tedavi Rehberi – 2023 Güncellemesi.

17.   Watchko JF, Maisels MJ. Treatment of hyperbilirubinemia in newborns. In: Buonocore G, Bracci R, Weindling M eds. Neonatology. Second edition. Springer International Publishing; 2018: 1185-1206.